Skip to main content

Fiscal Wizard · Single-issue tearsheet

LNTH / Jun 22, 2026 Run #7585

LNTH

Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. It also provides Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; PYLARIFY AI, an medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer; and flurpiridaz used to assess blood flow to the heart. In addition, it develops PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy to patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent for Tau tangles in Alzheimer's disease; LNTH-2401, a novel radiodiagnostic targeting the gastrin-releasing peptide receptor; LNTH-2402; LNTH-2403; LNTH-2404; LNTH-250; LNTH-2515; and LNTH-1363S, an fibroblast activation protein, alpha, copper-64 labeled PET imaging agent. It has collaboration agreements with GE Healthcare; Curium Pharma; POINT; Regeneron; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.

Composite verdict

B 68.0 / 100
Bullish setup · Trend Following 11 drivers · 2 gates blocking
  • Chaikin Money Flow
  • Fibonacci Retracement
  • Aroon Oscillator
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 7th of 85 in Drug Manufacturers - Specialty & Generic

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 24 signals0% Bear
Momentum Bullish 97Mean-reversion Neutral 51
  • Late-stage trendTrend signals have been live for 141 bars — past the ~60-bar window; momentum edge decays and can reverse late in a move. (medium confidence)
Where value comes fromMargin of safety -74%
Asset value $16.74Earnings power value $36.26Price $103.86

Priced above its no-growth earnings power value ($36.26/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Weak

36.3 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Greenblatt ROC 81
Margin of Safety 0
Return on Assets 79
OCF to Net Income 0
Return on Capital Employed 79
EPS Growth (YoY) 0

Technicals Bullish

99.8 / 100

Bullish setup leads (Chaikin Money Flow, Fibonacci Retracement, Aroon Oscillator); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Chaikin Money Flow 83
Fibonacci Retracement 79
Aroon Oscillator 78

Risk Gates

2 blocking 6 caution

2 guards active, 17 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Piotroski F-Score Caution

Bottom-band Piotroski F blocks bullish signals — fundamental-quality risk.

Quick Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for LNTH.